Indeed, a recent prospective study evaluated complement levels in bacteremia patients, and hypothesized the measurement of C3, C4 and C9 levels may help stratify Gram-negative bacteremia patients at increased risk for mortality [37]. This evidence concerns the gene C3 and bacterial infectious disease with sepsis.